ConductScience.org, home

Trial · NCT01843205

Participant flow12

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
First Treatment (11 Days)STARTEDPlacebo Then Buspirone5
First Treatment (11 Days)STARTEDBuspirone Then Placebo4
First Treatment (11 Days)COMPLETEDPlacebo Then Buspirone4
First Treatment (11 Days)COMPLETEDBuspirone Then Placebo4
First Treatment (11 Days)NOT COMPLETEDPlacebo Then Buspirone1
First Treatment (11 Days)NOT COMPLETEDBuspirone Then Placebo0
Second Treatment (11 Days)STARTEDPlacebo Then Buspirone4
Second Treatment (11 Days)STARTEDBuspirone Then Placebo4
Second Treatment (11 Days)COMPLETEDPlacebo Then Buspirone4
Second Treatment (11 Days)COMPLETEDBuspirone Then Placebo4
Second Treatment (11 Days)NOT COMPLETEDPlacebo Then Buspirone0
Second Treatment (11 Days)NOT COMPLETEDBuspirone Then Placebo0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01843205/flow